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Background
To examine the diagnostic accuracy of cardiac magnetic
resonance imaging (CMR) in differentiating thrombus
from myxoma Thrombus is thought not to enhance on
CMR, myxomas are thought to show mild heterogenous
enhancement on delayed imaging. It is sometimes difficult
to differentiate them, and this may lead to misdiagnosis,
which would significantly impact treatment. Thrombi can
have varying signal intensities depending on their age and
fibrous composition in T1 and T2 imaging.
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Figure 1 Images A-C: CMR demonstrating a mass with mild delayed enhancement suggestive of myxoma, later proven to be
thrombus; Images D-F: CMR demonstrating a mass diagnosed as myxoma, confirmed pathologically.
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Methods
A retrospective review of CMR performed from January
2000 to June 2013 was conducted with waiver of consent
which was approved by our institutional review board.
Analysis of a total of 46 masses diagnosed as myxoma or
thrombus on CMR were compared with histopathology
reports or follow up imaging to determine the diagnostic
accuracy of CMR. All patients underwent CMR on a 1.5
Tesla scanner with EKG gating following the same
protocol.
Results
Of the 46 masses reviewed, sixteen masses were diagnosed
as myxoma on CMR, while post-operative pathology
reports revealed 11 of these to be myxomas, 4 were found
to be thrombi, and 1 was an artifact associated with mitral
valve prosthesis. Of the 30 patients that were diagnosed
with thrombus, all were placed on anticoagulation
and monitored closely. One patient demonstrated no reso-
lution of mass at time of follow up, and subsequently
underwent surgery which revealed a myxoma. Of the 4
misdiagnosed myxoma cases, all had mild patchy delayed
enhancement on CMR imaging making differentiation dif-
ficult (Figure 1). Of the one misdiagnosed thrombus case,
the mass was very small and could only be seen as a non-
enhancing defect in contrast to the high signal seen on
first-pass. The positive predictive value for myxoma and
thrombus diagnosis by CMR is 69% and 97%, respectively.
Overall, CMR was able to correctly differentiate between
thrombus and myxoma in 87% of cases.
Conclusions
Delayed enhancement is one of the important factors
distinguishing a myxoma from a thrombus. However we
found in our study that some thrombi may show mild
delayed enhancement because of varying tissue composi-
tion and result in a misdiagnosis. CMR evaluation can
also be difficult in the presence of artifacts (motion,
valve prosthesis, intracardiac leads) and arrhythmias.
Thrombi may show patchy enhancement on delayed
imaging and can be confused as atrial myxoma on CMR.
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